StridesNSE -7.47 % Pharma Science on Friday said it has suspended sales of ulcer-treating tablet ranitidine in the US following the USFDA finding contamination in some of such medicines with potentially cancer causing impurities, N-nitrosodimethylamine (NDMA).
British drugmaker GlaxoSmithKlineNSE -0.23 % on Wednesday said it is recalling heartburn drug Ranitidine from India, a day after the country’s drug regulator asked pharma companies to check their products for carcinogen
As a precautionary measure, some manufacturers have already sent their ranitidine samples to laboratories for testing On 13 September, the USFDA had issued a safety alert citing the low-level presence of NDMA in ranitidine